Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I_Banker who wrote (292)	12/19/2004 12:45:29 AM
From: idahoranch1	Read Replies (1) of 371

I can tell you that Dr. Morton Coleman believes very strongly that E-mab works well in NHL, and he is one of the worlds leading authorities in NHL. He wants to see it approved, any way they can get it approved and he believes it will be an important product in managing NHL. He likes the combination approach. I believe that the company wants to see a partner run trials for lupus and NHL, the latter in combination with Rituxan. We also have our own CD20 in early human trials and at some point I expect to see that replace Rituxan in the combination if E-mab gets approved and the CD20 gets approved. That would be a while but it makes sense to me.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next